666 related articles for article (PubMed ID: 16861284)
1. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.
Stokman MA; Spijkervet FK; Boezen HM; Schouten JP; Roodenburg JL; de Vries EG
J Dent Res; 2006 Aug; 85(8):690-700. PubMed ID: 16861284
[TBL] [Abstract][Full Text] [Related]
2. Prevention of oral mucositis in cancer patients treated with chemotherapy or radiotherapy.
Richards D
Evid Based Dent; 2006; 7(4):106. PubMed ID: 17187046
[TBL] [Abstract][Full Text] [Related]
3. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
4. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Worthington HV; Clarkson JE; Eden OB
Cochrane Database Syst Rev; 2007 Oct; (4):CD000978. PubMed ID: 17943748
[TBL] [Abstract][Full Text] [Related]
5. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Worthington HV; Clarkson JE; Eden OB
Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
[TBL] [Abstract][Full Text] [Related]
6. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
Clarkson JE; Worthington HV; Eden OB
Cochrane Database Syst Rev; 2003; (3):CD000978. PubMed ID: 12917895
[TBL] [Abstract][Full Text] [Related]
7. Preventive intervention possibilities in radiotherapy- and chemotherapy- induced oral mucositis: results of meta-analyses. Authors failed to acknowledge the Cochrane review on this topic.
Worthington H; Clarkson J; Glenny AM
J Dent Res; 2006 Dec; 85(12):1085; author reply 1085-6. PubMed ID: 17122158
[No Abstract] [Full Text] [Related]
8. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
9. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
[TBL] [Abstract][Full Text] [Related]
10. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
[TBL] [Abstract][Full Text] [Related]
12. Management of oral mucositis induced by chemotherapy and radiotherapy: an update.
Vélez I; Tamara LA; Mintz S
Quintessence Int; 2004 Feb; 35(2):129-36. PubMed ID: 15000636
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
[TBL] [Abstract][Full Text] [Related]
14. [Current approaches in prevention and therapy of chemo- and radiotherapy-induced oral mucositis].
Rosenthal C; Karthaus M
Wien Med Wochenschr; 2001; 151(3-4):53-65. PubMed ID: 11789420
[TBL] [Abstract][Full Text] [Related]
15. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis.
Scully C; Sonis S; Diz PD
Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
18. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
[TBL] [Abstract][Full Text] [Related]
19. [Comments on five clinical trials concerning radiotherapy-induced mucositis in patients with head and neck neoplasms].
Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):202-4. PubMed ID: 11355589
[No Abstract] [Full Text] [Related]
20. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Lalla RV; Bowen J; Barasch A; Elting L; Epstein J; Keefe DM; McGuire DB; Migliorati C; Nicolatou-Galitis O; Peterson DE; Raber-Durlacher JE; Sonis ST; Elad S;
Cancer; 2014 May; 120(10):1453-61. PubMed ID: 24615748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
